Managing female urinary incontinence: A regional prospective analysis of cost-utility ratios (curs) and effectiveness

Elisabetta Costantini, Massimo Lazzeri, Vittorio Bini, Alessandro Zucchi, Emanuele Scarponi, Massimo Porena

Research output: Contribution to journalArticle

Abstract

Introduction: To evaluate the cost-utility of incontinence treatments, particularly anticholinergic therapy, by examining costs and quality-adjusted life years. Materials and methods: A prospective cohort study of women who were consecutively referred by general practitioners (GPs) to the Urology Department because of urinary incontinence. The primary outcome was evaluation of the cost-utility of incontinence treatments (surgery, medical therapy and physiotherapy) for stress and/or urgency incontinence by examining costs and quality-adjusted life years. Results: 137 consecutive female patients (mean age 60.6 ± 11.6; range 36-81) were enrolled and stratified according to pathologies: SUI and UUI. Group A: SUI grade II-III: 43 patients who underwent mid-urethral sling (MUS); Group B: SUI grade I-II 57 patients who underwent pelvic floor muscle exercise and Group C: UUI: 37 patients who underwent antimuscarinic treatment with 5 mg solifenacin daily. The cost utility ratio (CUR) was estimated as saving more than €1200 per QALY for surgery and physiotherapy and as costing under € 100 per QALY for drug therapy. Conclusions: This study shows that appropriate diagnosis and treatment of a patient with incontinence lowers National Health Service costs and improves the benefits of treatment and quality of life.

Original languageEnglish
Pages (from-to)112-117
Number of pages6
JournalArchivio Italiano di Urologia e Andrologia
Volume86
Issue number2
DOIs
Publication statusPublished - 2014

    Fingerprint

Keywords

  • Anti-muscarinic therapy
  • Cost-utility analysis
  • Female urinary incontinence
  • Mid urethral slings
  • Physiotherapy
  • Qaly

ASJC Scopus subject areas

  • Urology

Cite this